Seminar: Unlock the Future of Cell and Gene Therapy

Hosted by Aldevron and MaxCyte at the Leiden Biopark

Join us for an exclusive event hosted by Aldevron and MaxCyte, showcasing capabilities for cell and gene therapy development. Discover innovative solutions to accelerate your research and bring transformative therapies to life.

December 10, 2024

13.15-17.00

Kadans Meeting Room

Plus Ultra Leiden,

Leiden Bio Science Park,

Netherlands

Lunch will be provided. Space is limited, so we encourage you to reserve your spot today.

Presenters

• Alicia Roig-Merino, PhD 

Senior Field Application Scientist, MaxCyte

Development of non-viral T-cell therapies; Complex gene editing in hard-to-transfect cells.

• Maarten Walmagh

Business Development Manager, Aldevron

Nanoplasmid™, the power of small; CRISPR-based therapeutics and streamlining the path to commercialisation.